R Das

Latest

• Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
• Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer
• An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer